Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst Matthew Sykes downgraded the rating for Charles River Laboratories International, Inc. (NYSE:CRL) from Buy to Neutral and lowered the price target from $190 to $170. Charles River shares closed at $165.35 on Thursday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Matthew Caufield downgraded OptiNose, Inc. (NASDAQ:

Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst Matthew Sykes downgraded the rating for Charles River Laboratories International, Inc. (NYSE:CRL) from Buy to Neutral and lowered the price target from $190 to $170. Charles River shares closed at $165.35 on Thursday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Matthew Caufield downgraded OptiNose, Inc. (NASDAQ:

Full story available on Benzinga.com

 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Goldman Sachs analyst Matthew Sykes downgraded the rating for Charles River Laboratories International, Inc. (NYSE:CRL) from Buy to Neutral and lowered the price target from $190 to $170. Charles River shares closed at $165.35 on Thursday. See how other analysts view this stock.
HC Wainwright & Co. analyst Matthew Caufield downgraded OptiNose, Inc. (NASDAQ:Full story available on Benzinga.com   Read MoreCRL, FDS, FDX, News, OPTN, Top Downgrades, VMI, Downgrades, Markets, Analyst Ratings, Trading Ideas, CRL, US1598641074, FDS, US3030751057, FDX, US31428X1063, VMI, US9202531011, OPTN, News, Downgrades, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets